FY2024 EPS Estimates for KORU Medical Systems, Inc. (NASDAQ:KRMD) Lowered by Analyst

KORU Medical Systems, Inc. (NASDAQ:KRMD) – Investment analysts at B. Riley decreased their FY2024 earnings per share estimates for KORU Medical Systems in a report issued on Wednesday, May 1st. B. Riley analyst W. Wood now forecasts that the company will earn ($0.16) per share for the year, down from their previous estimate of ($0.15). B. Riley currently has a “Buy” rating and a $4.00 target price on the stock. The consensus estimate for KORU Medical Systems’ current full-year earnings is ($0.16) per share.

KORU Medical Systems Trading Down 0.4 %

Shares of KRMD opened at $2.31 on Monday. The company has a quick ratio of 3.37, a current ratio of 4.01 and a debt-to-equity ratio of 0.02. KORU Medical Systems has a 12-month low of $1.98 and a 12-month high of $4.30. The firm has a market capitalization of $105.71 million, a PE ratio of -8.25 and a beta of 0.55. The stock’s fifty day simple moving average is $2.21 and its 200-day simple moving average is $2.23.

KORU Medical Systems (NASDAQ:KRMD) last issued its quarterly earnings results on Wednesday, May 1st. The company reported ($0.02) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.04) by $0.02. KORU Medical Systems had a negative return on equity of 25.10% and a negative net margin of 45.24%. The business had revenue of $8.20 million for the quarter, compared to analyst estimates of $7.49 million. During the same quarter in the prior year, the firm posted ($0.05) earnings per share.

Hedge Funds Weigh In On KORU Medical Systems

Large investors have recently made changes to their positions in the company. Mesirow Financial Investment Management Inc. acquired a new position in shares of KORU Medical Systems during the first quarter valued at $26,000. Advisor Resource Council acquired a new position in KORU Medical Systems in the first quarter valued at about $63,000. Bard Associates Inc. lifted its stake in KORU Medical Systems by 22.5% in the fourth quarter. Bard Associates Inc. now owns 26,710 shares of the company’s stock valued at $66,000 after buying an additional 4,910 shares during the period. Eagle Asset Management Inc. lifted its stake in KORU Medical Systems by 70.1% in the third quarter. Eagle Asset Management Inc. now owns 54,096 shares of the company’s stock valued at $146,000 after buying an additional 22,299 shares during the period. Finally, White Pine Capital LLC acquired a new position in KORU Medical Systems in the third quarter valued at about $158,000. Institutional investors and hedge funds own 58.60% of the company’s stock.

About KORU Medical Systems

KORU Medical Systems, Inc develops and manufactures medical devices and supplies in the United States and internationally. It offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria.